---
title: Enrolling 1,000 Patients
description: Enrolling 1,000 Patients
---

[News ](https://www.yourway.com/news)

# [Enrolling 1,000 Patients](https://www.yourway.com/news/enrolling-1000-patients)

 Written by [Yourway](https://www.yourway.com/news/author/yourway) | May 21, 2020

Clinical testing has begun on Gilead’s antiviral drug remdesivir coupled with baricitinib, an anti-inflammatory medicine. The [enrollment](https://www.nih.gov/news-events/news-releases/nih-clinical-trial-testing-antiviral-remdesivir-plus-anti-inflammatory-drug-baricitinib-covid-19-begins) of more than 1,000 participants is ongoing. In addition to supporting clinical trials, Yourway can also provide all ancillary materials needed during a trial, no matter how large the scale.

[View full post](https://www.yourway.com/news/enrolling-1000-patients)

```json
{
  "@context" : "http://schema.org",
  "@type" : "BlogPosting",
  "author" : {
    "@type" : "Person",
    "name" : "Yourway"
  },
  "dateModified" : "2020-05-21T09:00:00.354Z",
  "datePublished" : "2020-05-21T09:00:00Z",
  "headline" : "Enrolling 1,000 Patients",
  "image" : {
    "@type" : "ImageObject",
    "height" : 4480,
    "url" : "https://cdn2.hubspot.net/hubfs/5402331/iStock-1221400792.jpg",
    "width" : 6720
  },
  "mainEntityOfPage" : "https://www.yourway.com/news/enrolling-1000-patients",
  "publisher" : {
    "@type" : "Organization",
    "logo" : {
      "@type" : "ImageObject",
      "height" : 60,
      "url" : "/hs/hsstatic/content_shared_assets/static-1.4092/img/default-amp-logo.png",
      "width" : 60
    },
    "name" : "News"
  }
}
```